The molecular signature of oncofusion proteins in acute myeloid leukemia

被引:76
作者
Martens, Joost H. A. [1 ]
Stunnenberg, Henk G. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
关键词
Acute myeloid leukemia; Oncofusion protein; Transcriptional regulation; Epigenetic; ACUTE PROMYELOCYTIC LEUKEMIA; SERUM RESPONSE FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; FUSION PROTEIN; TRANSCRIPTION FACTOR; RAR-ALPHA; HISTONE DEACETYLASE; HEMATOPOIETIC-CELLS;
D O I
10.1016/j.febslet.2010.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode onco-fusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2662 / 2669
页数:8
相关论文
共 50 条
  • [31] Molecular targeted therapy in acute myeloid leukemia
    Daver, Naval
    Cortes, Jorge
    HEMATOLOGY, 2012, 17 : S59 - S62
  • [32] Molecular characterization and testing in acute myeloid leukemia
    Gerald B. W. Wertheim
    Journal of Hematopathology, 2015, 8 : 177 - 189
  • [33] Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein
    Day, Ryan B.
    Hickman, Julia A.
    Xu, Ziheng
    Katerndahl, Casey D. S.
    Ferraro, Francesca
    Ramakrishnan, Sai Mukund
    Erdmann-Gilmore, Petra
    Sprung, Robert W.
    Mi, Yiling
    Townsend, R. Reid
    Miller, Christopher A.
    Ley, Timothy J.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (04)
  • [34] Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1
    Lugthart, Sanne
    Figueroa, Maria E.
    Bindels, Eric
    Skrabanek, Lucy
    Valk, Peter J. M.
    Li, Yushan
    Meyer, Stefan
    Erpelinck-Verschueren, Claudia
    Greally, John
    Lowenberg, Bob
    Melnick, Ari
    Delwel, Ruud
    BLOOD, 2011, 117 (01) : 234 - 241
  • [35] The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
    Gurnari, Carmelo
    Falconi, Giulia
    De Bellis, Eleonora
    Voso, Maria Teresa
    Fabiani, Emiliano
    CANCERS, 2019, 11 (06):
  • [36] Molecular diagnosis and monitoring of acute myeloid leukemia
    Biondi, A
    Rambaldi, A
    LEUKEMIA RESEARCH, 1996, 20 (10) : 801 - 807
  • [37] Hox gene dysregulation in acute myeloid leukemia
    De Braekeleer, Etienne
    Douet-Guilbert, Nathalie
    Basinko, Audrey
    Le Bris, Marie-Josee
    Morel, Frederic
    De Braekeleer, Marc
    FUTURE ONCOLOGY, 2014, 10 (03) : 475 - 495
  • [38] Drug Repurposing for the Treatment of Acute Myeloid Leukemia
    Andresen, Vibeke
    Gjertsen, Bjorn T.
    FRONTIERS IN MEDICINE, 2017, 4
  • [39] Childhood Acute Myeloid Leukemia: An Indian Perspective
    Kulkarni, Ketan Prasad
    Marwaha, Ram Kumar
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (04) : 257 - 268
  • [40] Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
    Petrov, Ivan
    Suntsova, Maria
    Mutorova, Olga
    Sorokin, Maxim
    Garazha, Andrew
    Ilnitskaya, Elena
    Spirin, Pavel
    Larin, Sergey
    Zhavoronkov, Alex
    Kovalchuk, Olga
    Prassolov, Vladimir
    Roumiantsev, Alexander
    Buzdin, Anton
    AGING-US, 2016, 8 (11): : 2936 - 2947